HOWL
HOWL
US95075A1079
Werewolf Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
47.61M EUR
17.5M EUR
40.48M EUR
30.81M EUR
Enterprise Value
22.24M EUR
-4.49M EUR
31.68M EUR
11.43M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-1.66x
--
--
--
Price to Sales
2.27x
0.83x
--
--
Price to Book
2.92x
1.07x
3.32x
1.24x
EV/Revenue
1.06x
-0.21x
--
--
EV/EBITDA
-1.01x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-25.7%
-172.32%
-128.31%
-134.19%
ende